Medacta Spotlights Leading Knee, Hip, Spine and Hip Preservation Surgical Practices and Innovations at 8th M.O.R.E. International Symposium

LUGANO, Switzerland--()--Medacta International, the privately held, family-owned global leader in the design of innovative joint replacement and spine surgery products, today kicks off its 8th Medacta Orthopedic Research and Education (M.O.R.E.) International Symposium near the company’s global headquarters in Lugano, Switzerland. Reflecting Medacta’s ongoing commitment to continuous medical education, the event will focus on how implant design, techniques and patient-specific treatment can improve outcomes and patient satisfaction in the changing orthopedic landscape.

“Surgical education and training has been a pillar of Medacta’s mission and identity since the company began. We believe that it is the foundation for optimal clinical outcomes and patient and surgeon satisfaction,” said Alberto Siccardi, President and Founder of Medacta International. “We are thrilled to dedicate two full days, and four distinct content tracks, to furthering this commitment at our largest M.O.R.E. International Symposium yet, with over 1,000 attendees from 30 countries.”

The 8th M.O.R.E. International Symposium features content tracks dedicated to knee, hip, spine and hip preservation technologies and techniques, including 20+ sessions with multiple clinical presentations. More than 80 orthopedic surgery experts will present at the meeting, with Chitranjan S. Ranawat (New York, USA) delivering the keynote address. Frédéric Laude (Paris, France) and Joel Matta (California, USA) will serve as chairmen of the Hip Program, which will also include welcoming remarks from the Orthopaedic Research and Education Foundation’s Richard F. Santore. David M. Manning (Illinois, USA) and Philippe Neyret (Lyon, France) will chair the Knee program, while Dezsö Jeszenszky (Zurich, Switzerland) will serve as Honorary Chairman of the Spine program. The new Hip Preservation program will be co-chaired by Marc Safran (California, USA) and Michael Dienst (Munich, Germany).

Knee Day (Friday, April 22) will focus on:

  • The effects of implant design and alignment on patient satisfaction
  • Developments in orthopedic procedures, including patient-matched technologies and single-use instrumentation
  • The growing trend of outpatient surgery

Hip Preservation Day, running concurrently on Friday, April 22, will address:

  • Open and arthroscopic hip surgery best practices
  • The professional transition between open and arthroscopic hip surgery
  • Technical recommendations for FAI and labral surgery
  • Mitigating complications in hip procedures such as osteoarthritis, persisting pain after THA hip instability, and dysplasia

Hip Day (Saturday, April 23) will include content on:

  • Variables that control outcomes influencing patient satisfaction
  • Addressing the “high demand” patient
  • The evolving anterior approach and its role in reducing or avoiding common complications
  • Anterior approach indications in revision hip arthroplasty

The Spine program will run simultaneously alongside the knee and hip tracks over the two-day period and will address:

  • Patient-matched technology and its impact on screw placement accuracy
  • Minimally invasive operating techniques
  • Sagittal Balance strategies and best surgical steps
  • Intervertebral fusion devices

“The practice of orthopedics is constantly evolving,” said Dr. David Manning, Vice Chair of Orthopedic Surgery at Northwestern University and co-chair of the Symposium’s Knee Day. “To provide patients with the best possible care, orthopedic surgeons must not only stay up to date on the latest clinical and scientific developments but also engage with their peers to discuss best practices, key challenges and experiences that can impact patient satisfaction and outcomes. With a faculty of globally renowned orthopedic experts and a program that addresses some of the most significant issues in our field, the M.O.R.E. International Symposium continues to be a vital forum for the clinical research, training and conversations that are shaping the future of orthopedic surgery.”

For more information about the 8th M.O.R.E. International Symposium, visit

About Medacta International

Medacta® International is a world leading manufacturer of orthopedic implants, neurosurgical systems, and instrumentation. Medacta’s revolutionary approach and responsible innovation have resulted in standard of care breakthroughs in hip replacement with the AMIS® system and total knee replacement with MyKnee® patient matched technology. Over the last 10 years, Medacta has grown dramatically by taking a holistic approach and placing value on all aspects of the care experience from design to training to sustainability. Medacta is headquartered in Castel San Pietro, Switzerland, and operates in over 30 countries. To learn more about Medacta International, please visit or follow @Medacta on Twitter.


For Medacta International
Jill Bongiorni, 516-729-2250

Release Summary

Medacta International today kicks off its 8th Medacta Orthopedic Research and Education (M.O.R.E.) International Symposium near the company’s global headquarters in Lugano, Switzerland.


For Medacta International
Jill Bongiorni, 516-729-2250